Pedro Vizán
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Cancer, Hypoxia, and Metabolism 6
- Cancer Genomics and Diagnostics 2
-
- Epigenetics and DNA Methylation 7
- Metabolism, Diabetes, and Cancer 6
- TGF-β signaling in diseases 5
- Cancer-related gene regulation 4
- Genomics and Chromatin Dynamics 4
- Co-authors
- Marta Cascante (11 shared papers)Luciano Di Croce (10 shared papers)Caroline S. Hill (5 shared papers)Sergi Aranda (4 shared papers)Anassuya Ramachandran (2 shared papers)Malte Beringer (3 shared papers)Debipriya Das (2 shared papers)Gema Alcarraz‐Vizán (3 shared papers)
- Journals
- eLife (2 papers)Frontiers in Cell and Developmental Biology (2 papers)Molecular and Cellular Biology (2 papers)Science Signaling (2 papers)Molecular Cell (2 papers)
- Partner nations
- SpainUnited KingdomUnited States
In The Last Decade
Pedro Vizán
28 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 102
- Cancer Research 397
- Genetics 224
- Pathology and Forensic Medicine 339
- Molecular Biology 1.1k
- Oncology 340
Countries citing papers authored by Pedro Vizán
This map shows the geographic impact of Pedro Vizán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pedro Vizán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pedro Vizán more than expected).
Fields of papers citing papers by Pedro Vizán
This network shows the impact of papers produced by Pedro Vizán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pedro Vizán. The network helps show where Pedro Vizán may publish in the future.
Co-authors
The 25 scholars most cited alongside Pedro Vizán, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 430 | |
| 2 | 2018 | 171 | |
| 3 | 2015 | 141 | |
| 4 | 2016 | 115 | |
| 5 | 2005 | 102 | |
| 6 | 2009 | 84 | |
| 7 | 2009 | 81 | |
| 8 | 2012 | 81 | |
| 9 | 2014 | 70 | |
| 10 | 2013 | 59 | |
| 11 | 2021 | 58 | |
| 12 | 2015 | 53 | |
| 13 | 2008 | 51 | |
| 14 | 2009 | 43 | |
| 15 | 2020 | 29 | |
| 16 | 2020 | 28 | |
| 17 | 2008 | 27 | |
| 18 | 2010 | 23 | |
| 19 | 2010 | 22 | |
| 20 | 2010 | 20 |
About Pedro Vizán
Pedro Vizán is a scholar working on Cancer Research, Molecular Biology, Pathology and Forensic Medicine, Hematology and Applied Microbiology and Biotechnology, having authored 28 papers that have together received 1.8k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (7 papers), Metabolism, Diabetes, and Cancer (6 papers), Cancer, Hypoxia, and Metabolism (6 papers), TGF-β signaling in diseases (5 papers), Genetic factors in colorectal cancer (5 papers), Cancer-related gene regulation (4 papers), Genomics and Chromatin Dynamics (4 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Cancer Research (397 citations), Genetics (224 citations), Pathology and Forensic Medicine (339 citations), Molecular Biology (1.1k citations) and Oncology (340 citations). Pedro Vizán has collaborated with scholars based in Spain, United Kingdom and United States. Frequent co-authors include Marta Cascante, Luciano Di Croce, Caroline S. Hill, Sergi Aranda, Anassuya Ramachandran, Malte Beringer, Debipriya Das, Gema Alcarraz‐Vizán, Cecilia Ballaré and Wilma M. Frederiks. Their work appears in journals such as eLife, Frontiers in Cell and Developmental Biology, Molecular and Cellular Biology, Science Signaling and Molecular Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.